Glymphatic Clearance

Glymphatic clearance is the brain's bulk-flow waste disposal: cerebrospinal fluid driven along periarterial spaces, through the parenchyma via aquaporin-4 channels at astrocyte endfeet, and out along perivenous and meningeal lymphatic routes. It matters to this corpus because it is the extracellular half of a clearance argument whose intracellular half is the lysosome — and because it is one of the few disease-relevant processes demonstrably gated by behaviour rather than by molecular state.

The claim, and who makes it here

Tsai (submission 116) reaches glymphatic clearance from an unexpected direction: gamma oscillations. The proposal is that 40 Hz activity is not a byproduct of neural computation but an active metabolic requirement, and that its disruption is a causal driver of pathology rather than a symptom of it. Restoring it by sensory entrainment (GENUS) produces downstream effects including microglial phagocytosis, bioenergetic resuscitation of the autophagy–lysosome pathway, and clearance itself.

The clearance evidence is specific: chronic GENUS increased the diameter of meningeal lymphatic vessels, modulated immune cells in the meninges, increased transporter localisation at astrocyte endfeet — promoting CSF influx — and increased efflux of exogenous amyloid from mouse brain.

That chain inverts the usual causal direction. Clearance is normally cast as something the disease impairs. Here it is something a circuit controls, and therefore something an intervention on the circuit can restore without touching the pathology directly.

The noradrenergic switch

The corpus's own clearance work hinges glymphatic function to the locus coeruleus, and this is where the concept becomes uncomfortable for the framework. Noradrenaline gates glymphatic flow — flow rises when noradrenergic tone falls, which is why the system runs during sleep. But the locus coeruleus is also the structure the framework identifies as the earliest site of tau pathology.

The result is a paradox the corpus names rather than resolves: the arsonist operates the sprinkler. The nucleus whose failure begins the disease is the same nucleus whose activity pattern controls the system that would clear it.

What is contested

The sleep–clearance literature is live and disputed, and this corpus records that rather than papering over it. The 2024 controversy — whether clearance genuinely rises during sleep, or whether the anaesthetic and tracer methods that established the claim produced it — is named in the clearance theses. Glymphatic claims here are therefore graded: the anatomy is established, the sleep-gating is contested, and the causal role in human Alzheimer's is inference.

Where it sits

Tsai's submission loads Neuroimmune Interface (6) and Endosomal Nexus (6) equally, which is the quantitative shape of the argument: clearance failure is simultaneously an immune problem (who does the phagocytosis) and a trafficking problem (what happens to what is taken up). The framework treats extracellular clearance as the companion to intracellular clearance rather than an alternative — two disposal routes for the same debris, failing on the same timeline.

Near-neighbours in this vault

Two further concepts cover the same ground from other submissions: Glymphatic clearance failure (Alix) and Glymphatic clearance failure amplifies pathology (Magadum). They are distinct entries because they enter the corpus through distinct papers, not because they name distinct mechanisms.

Advanced by

Submission 116, Li-Huei Tsai — gamma oscillations as a metabolic requirement; GENUS as clearance therapy.

Autophagic Flux · Lysosomal Dysfunction · Phagocytic Clearance · Locus coeruleus as ground zero · Proteostasis · Neuroimmune Interface